Dewpoint therapeutics logo
WebJan 30, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dewpoint Therapeutics, a company translating the emerging area of biomolecular condensates into drug discovery, launched today with a $60 million Series A ... WebOct 13, 2024 · Oct. 13, 2024, 06:00 AM. - Nathwani joins Dewpoint after serving as Chief Medical Officer, Chief Digital Officer, and Executive Committee member at Sanofi. BOSTON, Oct. 13, 2024 /PRNewswire ...
Dewpoint therapeutics logo
Did you know?
WebDewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. It offers genetically linked condensatopathy … WebMar 23, 2024 · Photo shows Novo Nordisk logo on building/Courtesy joreks/Getty Images Novo Nordisk and Dewpoint Therapeutics have inked a deal to use the latter's biomolecular condensates discovery platform to treat insulin resistance and …
WebTranslating condensate biology into medicine. We have assembled the most extraordinary talent in condensate science, drug discovery and data science, emerging as the world’s … WebJoin us. Dewpoint is the first company to apply this emerging understanding of biomolecular condensates to advance a revolutionary approach to drug discovery. We believe that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensates — including cancer, neurodegeneration ...
WebDewpoint General Information. Description. Developer of a healthcare technology designed to identify novel drugs across a wide spectrum of diseases. The company's technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine of a collection of engineered cell lines with trackable condensates to prevent … WebMar 22, 2024 · First biomolecular condensates research collaboration to identify drug candidates related to insulin resistance and diabetic complications ; Dewpoint is eligible to receive up to $55 million near term and up to $690 million of clinical, commercial and sales milestones plus royalties across two commercial products; BOSTON, March 22, 2024 …
WebOct 13, 2024 · BOSTON, Oct. 13, 2024 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, …
chip act detailsWebAug 17, 2024 · Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways... chip activated cat bowlWebFunding. Dewpoint Therapeutics has raised a total of $287M in funding over 3 rounds. Their latest funding was raised on Feb 3, 2024 from a Series C round. Dewpoint Therapeutics is funded by 16 investors. SoftBank Vision Fund and Mirae Asset Capital are the most recent investors. chip act newsWebOct 13, 2024 · /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced it has appointed Ameet Nathwani, M.D., as Chief Executive Officer... Dewpoint Therapeutics... grant county indiana zoning mapWebDewpoint Therapeutics. Boston, New York. Dewpoint Therapeutics Company Stats. Industry Biotechnology & Agriculture. Founded 2024. Headquarters Boston, New York. … grant county indiana work release programWebDec 20, 2024 · Palantir and Dewpoint Therapeutics Announce Strategic Partnership. December 20, 2024 06:59 AM Eastern Standard Time. DENVER & BOSTON-- ( … grant county industrial parkWebDewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates or arise from the dysfunction of condensa tes - including cancer, neurodegeneration, infectious disease, and metabolic ... grant county inmates